Wang, Q., Shi, J., Chai, X., Zheng, L., Wu, L., Mou, H., Lin, R., Qu, X., Liu, L., Xu, Q., Cao, D., Yao, Y., Wu, J. J. (2025). A phase 1 dose escalation and expansion study of ZG006, a trispecific T cell engager targeting CD3/DLL3/DLL3, as monotherapy in patients with refractory small cell lung cancer or neuroendocrine carcinoma.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.8089